Uniting Forces: Addressing Needs in Blood Cancer Care

Every year around 300,000 EU citizens receive a diagnosis for a haematalogical malignancy, including leukaemia, lymphoma, multiple myeloma. Each cancer type places its own unique demands on health systems and how they can best prevent, detect, diagnose, and treat these diseases.

 

To this end, the European Cancer Organisation is supporting the EU-funded research project SANGUINE to investigate novel approaches to early detection of these blood cancers. It is also bringing together its member societies, patient organisations and other entities to identify precisely what is needed for better blood cancer treatment.

 

We invite all interested stakeholders in Europe and around the world to join us we explore the latest developments in these fields and what they may mean for better blood cancer care.

 

Don't not miss out on this opportunity. Register now!

11 October 2024 15:00 - 17:00 CEST

Online

 Apply for Registration

SANGUINE Stakeholder Forum Web Banner

Advances in cancer research and biomedical technology have proven crucial in the detection and treatment of blood cancers, saving thousands of lives every year.

The SANGUINE project is building on this effort to develop a quick, minimally invasive, cost-effective, and highly sensitive screening and monitoring tool for blood cancers. It's called the HemaChip. If successful, it would lead to improved patient outcomes, reduced healthcare costs, and enhanced population-based screening programmes.

The European Cancer Organisation is part of the consortium of research organisations, medical institutions, universities and non-profit organisations working on the SANGUINE project.

To learn more about the project, visit the official website and join us online for a special stakeholder forum.  

11 October, between 15:00 and 17:00 CEST. Reserve your spot now by filling out the form above!

This digital event will bring together the leading voices in the cancer community to discuss technological innovations, best practices, and better public policies to improve treatment for blood-related diseases.

Discussion topics include:

  • Improving early detection for blood cancers;
  • Improving quality of cancer care for haematoligical malignancies;
  • EU policy and blood cancers.

Join the conversation to hear from experts, exchange ideas, and share your own perspective.

EN FundedbytheEU RGB POS

Related Resources